163 related articles for article (PubMed ID: 38445216)
1. Malignant Insulinoma Arising From Nonfunctioning Pancreatic Neuroendocrine Tumor.
Chatterjee R; Ali B; Nguyen SH; Chen R; Sada YH
ACG Case Rep J; 2023 Jan; 10(1):e00954. PubMed ID: 38445216
[TBL] [Abstract][Full Text] [Related]
2. Synchronous Insulinoma and Glucagonoma: A Review of the Literature.
Damaskos C; Dimitroulis D; Garmpi A; Antoniou EA; Kouraklis G; Psilopatis I; Mavri M; Diamantis E; Marinos G; Kyriakos G; Farmaki P; Patsouras A; Kontzoglou K; Garmpis N
In Vivo; 2023; 37(6):2402-2408. PubMed ID: 37905620
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic neuroendocrine tumors with transformation to insulinoma: an unusual presentation of a rare disease.
Nahmias A; Grozinsky-Glasberg S; Salmon A; Gross DJ
Endocrinol Diabetes Metab Case Rep; 2015; 2015():150032. PubMed ID: 26113980
[TBL] [Abstract][Full Text] [Related]
4. Report of a Novel Molecular Profile in Malignant Insulinoma.
Burns L; Naimi B; Ronan M; Xu H; Weber HC
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835815
[TBL] [Abstract][Full Text] [Related]
5. Pasireotide for Refractory Hypoglycemia in Malignant Insulinoma- Case Report and Review of the Literature.
Oziel-Taieb S; Maniry-Quellier J; Chanez B; Poizat F; Ewald J; Niccoli P
Front Endocrinol (Lausanne); 2022; 13():860614. PubMed ID: 35518928
[TBL] [Abstract][Full Text] [Related]
6. Prognosis after surgery for multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors: Functionality matters.
van Beek DJ; Nell S; Verkooijen HM; Borel Rinkes IHM; Valk GD; ; Vriens MR; ;
Surgery; 2021 Apr; 169(4):963-973. PubMed ID: 33220975
[TBL] [Abstract][Full Text] [Related]
7. Prompt resolution of hypoglycemia by hepatic transarterial embolization for malignant insulinoma with multiple liver metastases.
Muro S; Nasu J; Harada R; Matsubara M; Nakarai A; Kanzaki H; Tsutsumi K; Kato H; Tanaka T; Fujiwara H; Uno M; Okada H; Yamamoto K
Acta Med Okayama; 2014; 68(5):303-6. PubMed ID: 25338488
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic targeting of tumor-associated macrophages in pancreatic neuroendocrine tumors.
Krug S; Abbassi R; Griesmann H; Sipos B; Wiese D; Rexin P; Blank A; Perren A; Haybaeck J; Hüttelmaier S; Rinke A; Gress TM; Michl P
Int J Cancer; 2018 Oct; 143(7):1806-1816. PubMed ID: 29696624
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic neuroendocrine tumors.
Batcher E; Madaj P; Gianoukakis AG
Endocr Res; 2011; 36(1):35-43. PubMed ID: 21226566
[TBL] [Abstract][Full Text] [Related]
10. Chromogranin A is a reliable serum diagnostic biomarker for pancreatic neuroendocrine tumors but not for insulinomas.
Qiao XW; Qiu L; Chen YJ; Meng CT; Sun Z; Bai CM; Zhao DC; Zhang TP; Zhao YP; Song YL; Wang YH; Chen J; Lu CM
BMC Endocr Disord; 2014 Aug; 14():64. PubMed ID: 25099181
[TBL] [Abstract][Full Text] [Related]
11. Determinants of surgical resection for pancreatic neuroendocrine tumors.
Doi R
J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):610-7. PubMed ID: 25773163
[TBL] [Abstract][Full Text] [Related]
12. Case presentation of 8-year follow up of recurrent malignant duodenal Insulinoma and lymph node metastases and literature review of malignant Insulinoma management.
Walker MP; Shenoy V; Metz DC; Stanley CA; Fraker D; Chandrasekhara V; Amaro A
BMC Endocr Disord; 2022 Dec; 22(1):310. PubMed ID: 36494838
[TBL] [Abstract][Full Text] [Related]
13. Balancing efficacy and adverse reactions using everolimus in a patient with metastatic malignant insulinoma: Case report.
Rouf S; Boujtat K; El Harroudi T; Latrech H
Int J Clin Pharmacol Ther; 2024 Jun; 62(6):278-283. PubMed ID: 38431828
[TBL] [Abstract][Full Text] [Related]
14. Hepatic Artery Embolization for Palliation of Symptomatic Hypoglycemia in Patients With Hepatic Insulinoma Metastases.
Linch F; Thompson S; Fleming C; Vella A; Andrews J
J Endocr Soc; 2021 Dec; 5(12):bvab149. PubMed ID: 34877442
[TBL] [Abstract][Full Text] [Related]
15. Complete clinical remission and disappearance of liver metastases after treatment with somatostatin analogue in a 40-year-old woman with a malignant insulinoma positive for somatostatin receptors type 2.
Romeo S; Milione M; Gatti A; Fallarino M; Corleto V; Morano S; Baroni MG
Horm Res; 2006; 65(3):120-5. PubMed ID: 16479142
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic Neuroendocrine Tumor Producing Insulin and Vasopressin.
Alshaikh OM; Yoon JY; Chan BA; Krzyzanowska MK; Butany J; Asa SL; Ezzat S
Endocr Pathol; 2018 Mar; 29(1):15-20. PubMed ID: 28718084
[TBL] [Abstract][Full Text] [Related]
17. Transformation of nonfunctioning pancreatic tumor into malignant insulinoma after 3 years: an uncommon clinical course of insulinoma.
Arslan MS; Ozbek M; Karakose M; Tutal E; Ucan B; Yilmazer D; Dilli A; Gultekin SS; Cakal E; Delibasi T
Arch Endocrinol Metab; 2015 Jun; 59(3):270-2. PubMed ID: 26154097
[TBL] [Abstract][Full Text] [Related]
18. Transformation of nonfunctioning pancreatic neuroendocrine carcinoma cells into insulin producing cells after treatment with sunitinib.
Ohn JH; Kim YG; Lee SH; Jung HS
Endocrinol Metab (Seoul); 2013 Jun; 28(2):149-52. PubMed ID: 24396670
[TBL] [Abstract][Full Text] [Related]
19. Management of intractable hypoglycemia with Yttirum-90 radioembolization in a patient with malignant insulinoma.
Chandra P; Yarandi SS; Khazai N; Jacobs S; Umpierrez GE
Am J Med Sci; 2010 Nov; 340(5):414-7. PubMed ID: 20724903
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous Microwave Ablation of an Insulinoma in a Patient with Refractory Symptomatic Hypoglycemia.
Chen OT; Dojki FK; Weber SM; Hinshaw JL
J Gastrointest Surg; 2015 Jul; 19(7):1378-81. PubMed ID: 25941027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
